A Clinical Study to Evaluate the effect of Chitrak Haritaki Avaleha and Haridradi Leha on Nasal Allergy Symptoms in patients Suffering from Vataja Pratishyaya(Allergic Rhinitis).

A RANDOMIZED COMPARATIVE CLINICAL TRIAL ON THE EFFICACY OF CHITRAK HARITAKI AVLEHA AND HARIDRADI LEHA IN VATAJA PRATISHYAYA WITH SPECIAL REFERENCE TO ALLERGIC RHINITIS. - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099745

Enrollment

Registered

2025-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: Haridradi Leha: Haridradi Leha7 It is mentioned in Chakradatta Samhita in Hikka Shwasa Rogadhikara.It consists of 8 Dravyas namely Haridra, Maricha, Draksha, Guda, Rasna, Pippali,

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients willing to participate in the study 2 Patients of either sex aged between 18 60 years presenting with clinical sign and symptoms of Vataja Pratishyaya (Allergic Rhinitis) described as per Ayurveda and Modern science will be included in the study. 3 The diagnosis of the diseases shall be done with sign and symptoms of Vataja Pratishyaya (Allergic Rhinitis) Vataja Pratishyaya lakshana - Shirohshoola /Shirogaurava (Headache) - Tanusravapravartan (Rhinorrhea) - Kshavathu (Sneezing) - Aanaddha Nasa (Nasal obstruction) - Swaropaghata (Hoarseness of voice) - Kasa (Cough) - Kandu (Itching) 4 Nasal Congestion grade between 1 to 3(mild to moderate nasal congestion) will be included 5 Turbinate hypertrophy - grade between 1 to 3(mild to moderate Turbinate hypertrophy) will be included 6 Total nasal symptoms score- grade between 1 to 9 will be included

Exclusion criteria

Exclusion criteria: 1 Patients having history of uncontrolled systemic disease such as Diabetes Mellitus, Hypertension etc. 2 Patients suffering from gross deviation of Nasal Septum, Nasal Tumors, Adenoid Hyperplasia. 3 Patients not fit for Marsh Nasya 4 Other nasal conditions which may mimic or compound the presentation of Allergic Rhinitis like Nasal Polyps, Tumors etc. 5 Severe nasal obstruction 6 Patients on steroids or anti allergic medications.

Design outcomes

Primary

Measure	Time frame
Clinical improvement in symptoms of vataja pratishyaya [Allergic Rhinitis] assessed through the TNSS (Total nasal symptoms score) .Timepoint: 30days	—

Secondary

Measure	Time frame
Secondary outcome- o Changes in IgE level and AEC o Improvement in sign and symptoms of Vataja Pratishyaya i.e. Shirohshoola/Shirogaurava(Headache),Tanusravapravartan(Rhinorrhea),Kshavat hu(Sneezing),Aanaddha Nasa (Nasal obstruction),Swaropaghata (Hoarseness of voice),Kasa (Cough),Kandu (Itching)Timepoint: Secondary Endpoints- o changes in IgE level and AEC count after 8 weeks of intervention o Improvement in sign and symptoms of Vataja Pratishyaya i.e. Shirohshoola/Shirogaurava(Headache),Tanusravapravartan(Rhinorrhea),Kshavat hu(Sneezing),Aanaddha Nasa (Nasal obstruction),Swaropaghata (Hoarseness of voice),Kasa (Cough),Kandu (Itching) after 8 weeks of intervention	—

Measure

Time frame

Secondary outcome- o Changes in IgE level and AEC o Improvement in sign and symptoms of Vataja Pratishyaya i.e. Shirohshoola/Shirogaurava(Headache),Tanusravapravartan(Rhinorrhea),Kshavat hu(Sneezing),Aanaddha Nasa (Nasal obstruction),Swaropaghata (Hoarseness of voice),Kasa (Cough),Kandu (Itching)Timepoint: Secondary Endpoints- o changes in IgE level and AEC count after 8 weeks of intervention o Improvement in sign and symptoms of Vataja Pratishyaya i.e. Shirohshoola/Shirogaurava(Headache),Tanusravapravartan(Rhinorrhea),Kshavat hu(Sneezing),Aanaddha Nasa (Nasal obstruction),Swaropaghata (Hoarseness of voice),Kasa (Cough),Kandu (Itching) after 8 weeks of intervention

—

Countries

India

Contacts

Public ContactNEETU SINGH MEENA

NATIONAL INSTITUTE OF AYURVEDA,MADHAV VILAS ,JAIPUR

pamnani.gulab@gmail.com9461154942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026